Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $115,796 - $129,021
-1,149 Reduced 33.59%
2,272 $248,000
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $307,239 - $361,639
-3,172 Reduced 48.11%
3,421 $346,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $441,268 - $517,675
-4,642 Reduced 41.32%
6,593 $724,000
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $529,664 - $613,252
5,474 Added 95.02%
11,235 $1.09 Million
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $248,744 - $300,652
2,437 Added 73.32%
5,761 $626,000
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $326,211 - $397,793
-2,861 Reduced 46.26%
3,324 $393,000
Q4 2021

Jan 18, 2022

SELL
$115.53 - $141.46 $452,299 - $553,815
-3,915 Reduced 38.76%
6,185 $870,000
Q3 2021

Oct 20, 2021

BUY
$116.66 - $129.06 $303,082 - $335,297
2,598 Added 34.63%
10,100 $1.19 Million
Q2 2021

Jul 19, 2021

BUY
$105.79 - $124.53 $793,636 - $934,224
7,502 New
7,502 $870,000
Q1 2019

May 09, 2019

SELL
$66.22 - $80.06 $1.23 Million - $1.48 Million
-18,500 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$65.56 - $74.27 $2.43 Million - $2.75 Million
-37,000 Reduced 66.67%
18,500 $1.34 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $121,620 - $146,720
-2,000 Reduced 3.48%
55,500 $4.07 Million
Q2 2018

Jul 27, 2018

BUY
$57.57 - $63.54 $3.31 Million - $3.65 Million
57,500 New
57,500 $3.51 Million
Q1 2018

May 01, 2018

SELL
$56.27 - $63.62 $18.2 Million - $20.6 Million
-323,500 Closed
0 $0
Q4 2017

Feb 01, 2018

BUY
$53.68 - $57.47 $15.7 Million - $16.8 Million
291,700 Added 917.3%
323,500 $18.5 Million
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $1.53 Million - $1.71 Million
31,800
31,800 $1.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.